Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Four-year results of an open-label extension of 2 randomized clinical trials: TAP report no. 7 [4]

Archives of Ophthalmology

Volumn 123, Issue 9, 2005, Pages 1283-1285

  Bressler, Neil M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PLACEBO; PHOTOSENSITIZING AGENT; PORPHYRIN;

CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; HUMAN; INCIDENCE; LETTER; OUTCOMES RESEARCH; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; SAFETY; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY; AGED; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; MALE; NOTE; PHOTOCHEMOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA DEGENERATION; TIME;

AGED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TIME FACTORS; VISUAL ACUITY;

EID: 24944484230     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.9.1283     Document Type: Letter

References (2)

1. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol. 2001;119:198-207.
2. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an openlabel extension of 2 randomized clinical trials - TAP Report No. 5. Arch Ophthalmol. 2002;120:1307-1314.